Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
about
Vasculitis update: pathogenesis and biomarkers.Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis ReferraClinical trials in antineutrophil cytoplasmic antibody-associated vasculitis: what we have learnt so far, and what we still have to learn.Pituitary dysfunction in granulomatosis with polyangiitis.Difference in relapse-rate and clinical phenotype by autoantibody-subtype in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.Clinical trials in rheumatology. Does one size fit all?Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis.[S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis].Towards precision medicine in ANCA-associated vasculitis.Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides.Antineutrophil cytoplasmic antibody associated vasculitides with renal involvement: Open challenges in the remission induction therapy.Vasculitis Pathogenesis: Can We Talk About Precision Medicine?
P2860
Q38645654-BD7D56A0-60E5-4D8D-A297-236AD729B2DBQ38873411-543102CA-0DF6-4C14-9506-094A4F461BD9Q39088103-580279B2-68CC-46FE-8E12-D983994E4EB9Q39328177-92543B47-F59C-4788-A3BB-C1C9E144DEB0Q39671728-F2095B4A-C7A1-4853-9B10-FBF8F685FFF1Q47295847-1C5AF228-90A4-4F1F-AF10-6968F2CFC1ECQ50014741-C6DA5CE7-4269-4E67-A390-CB2B9050A64DQ50076914-E32BF4CC-57E2-4AF0-8476-8B93FBED08BFQ50089937-E8E81B59-615A-4CB7-B3A2-9F86E43D879BQ52311683-E5B203D7-7FEB-4B93-B5E0-44CA85257069Q55340553-FFD304B2-9374-4A9D-B8BA-A98E12D73BABQ58781578-56C43274-B616-4E1D-B058-757B7A6542D1
P2860
Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Clinical outcomes of treatment ...... vasculitis based on ANCA type.
@en
Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody
@nl
type
label
Clinical outcomes of treatment ...... vasculitis based on ANCA type.
@en
Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody
@nl
prefLabel
Clinical outcomes of treatment ...... vasculitis based on ANCA type.
@en
Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody
@nl
P2093
P2860
P1476
Clinical outcomes of treatment ...... vasculitis based on ANCA type.
@en
P2093
Carol A Langford
Cg M Kallenberg
David Ikle
E William St Clair
Eli M Miloslavsky
Fernando Fervenza
Gary S Hoffman
Hyon K Choi
John H Stone
Linna Ding
P2860
P304
P356
10.1136/ANNRHEUMDIS-2015-208073
P407
P577
2015-11-30T00:00:00Z